Absence of Borrelia burgdorferi antibodies in the sera of Venezuelan patients with localized scleroderma (morphea)

Investigacion Clinica

Volumn 47, Issue 3, 2006, Pages 283-288

  Espinoza León, Fabiola ^a,b   Hassanhi Hassanhi, Manzur ^b   Arocha Sandoval, Francisco ^a   Urbina López, Maricela ^a  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

^b UNIVERSIDAD DEL ZULIA   (Venezuela)

Author keywords

Borrelia burgdorferi; Localized scleroderma (morphea); Lyme borreliosis; Venezuela

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BORRELIA BURGDORFERI; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LOCALIZED SCLERODERMA; MORPHEA; SEROLOGY; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; ANTIBODIES, BACTERIAL; BORRELIA BURGDORFERI; CHILD; HUMANS; MIDDLE AGED; SCLERODERMA, LOCALIZED; VENEZUELA;

EID: 33750082357     PISSN: 05355133     EISSN: 05355133     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Sehgal VN, Srivastava G, Aggarwal AK, Behl PN, Choudhary M, Bajaj P. Localized scleroderma/morphea. Int J Dermatol 2002; 41:467-475.
2. Peterson LS, Nelson AM, Su WP, Mason T, O'Fallon WM, Gabriel SE. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993. J Rheumatol 1997; 24:73-80.
3. Weide B, Walz T, Garbe C. Is morphoea caused by Borrelia burgdorferi? A review. Br J Dermatol 2000; 142:636-644.
4. Arocha F, Amesty A, Urbina M, Durango A, Vargas H. Detección de anticuerpos contra Borrelia burgdorferi en una muestra poblacional del Estado Zulia. Invest Clin 1994; 35:91-104.
5. Palacios R, Osorio L, Giraldo L, Torres A, Philipp M, Ochoa M. Positive IgG Western Blot for Borrelia burgdorferi in Colombia. Mem Inst Oswaldo Cruz 1999; 94:499-503.
6. Center for Disease and Control Prevention. Recommendations for Test Performance and Interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. Morb Mort Wkly Rep 1995; 44:590-591.
7. Palacios R, Torres A, Trujillo R. IgG antibody reactivity to Borrelia burgdorferi sensu stricto antigens in patients with morphea in Colombia. Int J Dermatol 2003; 42:882-886.
8. Aberer E, Neumann R, Stanek G. Is localized scleroderma a borrelia infection?. Lancet 1985; 2:278.
9. Aberer E, Stanek G. Histological evidence for spirochetal origin of morphea and lichen sclerosus et atrophicans. Am J Dermatopathol 1987; 9:374-379.
10. Aberer E, Stanek G, Ertl M, Neumann R. Evidence for spirochetal origin of circumscribed scleroderma (morphea). Acta Derma Venereol 1987; 67:225-231.
11. Weber K, Preac-Mursic V, Reimers CD. Spirochetes isolated from two patients with morphea. Infection 1988; 16:25-26.
12. Breier FH, Aberer E, Stanek G, Khanakaha G, Schlick A, Tappeiner G. Isolation of Borrelia afzelii from circumscribed scleroderma. Br J Dermatol 1999; 140:925-930.
13. Aberer E, Klade H, Stanek G, Gebhart W. Borrelia burgdorferi and different types of morphea. Dermatologica 1991; 82:145-154.
14. Nakashima T, Maeda M, Hayashi T, Kitamura K. A case of generalized morphea with a high titer of anti-Borrelia burgdorferi antibodies. J Dermatol 1999; 26:821-824.
15. Wojas-Pelc A, Wielowieyska-Szybinska D, Kieltyka A. Presence of the antinuclear antibodies and antibodies to Borrelia burgdorferi among patients with morphea en plaque, deep linear scleroderma and atrophoderma Pasini-Pierini. Przegl Lek 2002; 59:898-902.
16. Schempp C, Bocklage H, Lange R, Kolmel H, Orfanos C, Gollnick H. Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confirmed by DNA amplification. J Invest Dermatol 1993; 100:717-720.
17. Ozkan S, Atabey N, Fetil E, Erkizan V, Gunes A. Evidence for Borrelia burgdorferi in morphea and lichen sclerosus. Int J Dermatol 2000; 39:278-283.
18. Dillon W, Saed G, Fivenson D. Borrelia burgdorferi DNA is undetectable by PCR in skin lesions of morphea, schleroderma or lichen sclerosus et atrophicus of patients from North America. J Am Acad Dermatol 1995; 33:617-620.
19. De Vito J, Merogi A, Vo T, Boh E, Fung H, Freeman SM, Cockerell C, Stewart K, Marrogi AJ. Role of Borrelia burgdorferi in the pathogenesis of morphea/scleroderma and lichen sclerosus et atrophicus: a PCR study of thirty-five cases. J Cutan Pathol 1996; 23:350-358.
20. Fujiwara H, Fujiwara K, Hashimoto K, Mehregan AH, Schaumburg-Lever G, Lange R, Schempp C, Gollnick H. Detection of Borrelia burgdorferi DNA (B. garinii or B. afzelii) in morphea and lichen sclerosus et atrophicus tissues of German and Japanese but not of US patients. Arch Dermatol 1997; 133:41-44.
21. Balmetti T, Pifferetti J. Association between different clinical manifestations of Lyme disease and different species of Borrelia burgdorferi sensu lato. Res Microbiol 1995; 146:329-340.
22. Schmidt BL. PCR in laboratory diagnosis of human Borrelia burgdorferi infections. Clin Microbiol Rev 1997; 10:185-201.
23. Sánchez B, Álvarez C, Morales Z, Cherubini B. Enfermedad de Lyme: reporte de un caso. Rev. Col. med. estado Táchira 1998: 7:41-42.
24. Burkot T, Schriefer M, Larsen S. Cross-reactivity to Borrelia burdorferi proteins in serum samples from residents of a tropical country nonendemic for Lyme Disease. J Infect Dis 1997; 175:466-469.
25. Brown S, Hansen S, Langone J. Role of serology in the diagnosis of Lyme disease. JAMA 1999; 282:62-66.